Elenagen, a p62/SQSTM1-encoding plasmid, improves overall survival in patients with platinum-resistant ovarian cancer: a phase II trial
Aliona Filimonava, Olga Streltsova, Y. Baranau, S. Polyakov et al.
Journal
International Journal of Gynecological Cancer
Topics
Cancer Research and Treatments
article
Elenagen, a p62/SQSTM1-encoding plasmid, improves overall survival in patients with platinum-resistant ovarian cancer: a phase II trial
Aliona Filimonava, Olga Streltsova, Y. Baranau, S. Polyakov, Alexander Shneider, Vladimir L. Gabai, S. А. Krasny, Ekaterina Zharkova, Gabriel Levin, Evgeny Bakin
article en
Abstract
No abstract available for this paper.
Publication Tag
International Journal of Gynecological Cancer
Institutions
ORT Israel (IL), McGill University Health Centre (CA), AVEO Oncology (United States) (US), 9th City Clinical Hospital (BY), N.N. Alexandrov National Cancer Centre (BY), McGill University (CA), Ariel University (IL)